SINGLE DOMAIN ANTIBODY PROGRAMMED DEATH-LIGAND (PD-L1) AND DERIVED PROTEIN THEREOF

• 收藏
• 分享

专利权人:

SUZHOU ALPHAMAB CO., LTD.; LTD.;3D MEDICINES (BEIJING) CO., LTD.;3D MEDICINES (BEIJING) CO.

发明人:

XU, Ting,DONG, Yanrong,WANG, Pilin,CHEN, Ting

申请号：

PH12018500233

公开号：

PH12018500233A1

申请日:

2018.01.29

申请国别(地区):

PH

年份:

2018

代理人:

摘要：

The present invention relates to the biomedical field, and provides a single domain antibody for programmed death-ligand (PD-L1) and a derived protein thereof. The present invention also provides a use of a PD-L1 binding molecule in treating and/or preventing and diagnosing a PD-L1 related disease, such as tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/